|
From the Clinical Knowledge Center
November Is Lung Cancer Awareness Month
From 1996 to 2003, only 16% of lung cancer was diagnosed at an early, more treatable stage. By contrast, 61% of breast cancers, 39% of colon cancers, and 91% of prostate cancers were diagnosed at an early stage. These diseases are in the forefront of the public’s awareness and screening for these cancers is strongly encouraged...
> Read
entire article
> Back to top
Compass Questions™
> Back to top
Responses from Last Compass Questions™
In the 11.04.08
issue of Clinical Compass™, we asked two questions.
Question #1 was "How often do you talk with your patients about the risks of drowsy driving?" and the neuroscienceCME learning community responded:
17.8% - Often
36.4% - Sometimes
24.0% - Rarely
21.7% - Never
Question #2 was "How confident are you in screening your patients for sleep disorders?" and the neuroscienceCME learning community responded:
17.1% - Very confident
27.9% - Confident
34.9% - Somewhat confident
20.2% - Not confident
> Back to top
New neuroscienceCME TV
Premieres Tomorrow!
The Broken Continuum of Care: Addressing a Crisis in the Care of Patients with Schizophrenia
Premiere Date: Wednesday, November 19, 2008
Live Broadcast: 12:00-1:00 p.m. ET
"After the Show" live Q&A webcast: 1:02 p.m. ET
Please note that this presentation is current as of November 19, 2008. The Joint Commission reserves the right to change the content of the information as appropriate.
Activity Goal
To provide mental health care practitioners with strategies, drawn from the evidence-base as well as from Joint Commission standards, for providing integrated, coordinated, and multidisciplinary care to patients with schizophrenia to facilitate improved adherence and to optimize functional outcome.
Learning Objectives
At the end of this CE activity, participants should be able to:
- Recognize and address gaps in the continuum of care of patients with schizophrenia based on available evidence as well as Joint Commission behavioral standards.
- Identify members of the treatment team and their respective roles in providing integrated and coordinated care.
- Develop a multidisciplinary team approach to helping improve treatment adherence in patients with schizophrenia.
Credit Information
This activity offers CE credit for:
- Physicians (ACCME/AMA PRA Category 1)
- Nurses (CNE)
- Pharmacists (ACPE)
- Psychologists (APA)
- Social Workers (NASW)
- Certified Case Managers (CCMC)
All other clinicians will either receive a CME Attendance Certificate or may choose any of the types of CE credit being offered.
> View activity details
> Add to calendar
> Register now
> Pre-order online
> Back to top
New neuroscienceCME Journal Club
with Live Q&A November 24, 2008!
Adherence and Early Predictors of Response: Tools for Individualizing Treatment in Schizophrenia
Bonus live Q&A date: Monday, November 24, 2008
Bonus live Q&A time: 12:00-12:45 p.m. ET (Kane/Green)
Be advised that participation in the bonus Q&A session does not constitute additional credit or Live ACPE credit.
Featured Article
Leucht S, Busch R, Kissling W, Kane JM. Early prediction of antipsychotic nonresponse among patients with schizophrenia. J Clin Psychiatry 2007;68:352-360.
> View abstract
Summary - Conventional wisdom holds that the therapeutic effects of antipsychotics take several weeks to emerge; and consequently, clinicians should wait as long as 4 weeks after starting a drug trial to deem a patient nonresponsive. Recent data, however, indicate that antipsychotic drug effects can be detected sooner than expected; and therefore, nonresponders may be able to be identified and switched to a more effective medication sooner. This study pooled and analyzed data from 7 controlled clinical trials of 1708 patients with schizophrenia to identify early predictors of nonresponse at week 4 based on reduction in Brief Psychiatric Rating Scale scores or clinician determination of no remission. Results indicate that little or no response to antipsychotic medication at weeks 1 and 2 was strongly predictive of nonresponse at week 4. These results suggest that patients can be evaluated for nonresponse as early as 2 weeks after starting treatment, and if appropriate, can be switched to an alternative medication earlier.
Activity Goal
To provide mental healthcare practitioners with the most recent data and clinical implications related to optimizing maintenance therapy in schizophrenia.
Learning Objectives
At the end of this CE activity, participants should be able to:
- Discuss the implications of differential efficacy and tolerability of antipsychotics on medication adherence.
- Identify targeted behavioral approaches to improving treatment adherence in patients with schizophrenia.
- Describe early predictors of response to antipsychotic medication in patients with schizophrenia.
> View activity details
> Add to calendar
> Register now
> Back to top
|
In This Issue
Live CME/CE
